• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. 
    •   QMRO Home
    • Blizard Institute
    • Centre for Immunobiology
    • Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management.
    •   QMRO Home
    • Blizard Institute
    • Centre for Immunobiology
    • Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management.
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management.

    Volume
    99
    Pagination
    1671 - 1676
    DOI
    10.3324/haematol.2014.111492
    Issue
    11
    Metadata
    Show full item record
    Abstract
    Intravenous iron is widely used for the treatment of iron deficiency anemia when oral iron is inappropriate, ineffective or poorly tolerated. Acute hypersensitivity reactions during iron infusions are very rare but can be life-threatening. This paper reviews their frequency, pathogenesis and risk factors, and provides recommendations about their management and prevention. Complement activation-related pseudo-allergy triggered by iron nanoparticles is probably a more frequent pathogenetic mechanism in acute reactions to current formulations of intravenous iron than is an immunological IgE-mediated response. Major risk factors for hypersensitivity reactions include a previous reaction to an iron infusion, a fast iron infusion rate, multiple drug allergies, severe atopy, and possibly systemic inflammatory diseases. Early pregnancy is a contraindication to iron infusions, while old age and serious co-morbidity may worsen the impact of acute reactions if they occur. Management of iron infusions requires meticulous observation, and, in the event of an adverse reaction, prompt recognition and severity-related interventions by well-trained medical and nursing staff.
    Authors
    Rampton, D; Folkersen, J; Fishbane, S; Hedenus, M; Howaldt, S; Locatelli, F; Patni, S; Szebeni, J; Weiss, G
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/6679
    Collections
    • Centre for Immunobiology [921]
    Language
    eng
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.